Patent Grant
7842382
The present disclosure pertains to binder compositions for non-woven fibers. In particular, the present disclosure pertains to thermally-curable, polyester binders for non-woven fibers.
Fiberglass insulation products generally include matted glass fibers that are held together by a cured thermoset polymeric resole resin. During production of such products, streams of molten glass are drawn into fibers of varying lengths and then blown into a forming chamber where they are deposited with little organization, or in varying patterns, as a mat onto a traveling conveyor. The fibers, while in transit in the forming chamber and while still hot from the drawing operation, are sprayed with an aqueous resin binder solution. The residual heat from the glass fibers and the flow of air through the fibrous mat during the forming operation will generally evaporate most of the water from the resin binder, thereby leaving the remaining components of the binder on the fibers as a viscous or semi-viscous high-solids liquid, thereby forming a “wet blanket.” The coated fibrous mat or wet blanket, which is formed in a compressed state due to the high-velocity flow of air through the mat in the forming chamber, is then transferred out of the forming chamber to a transfer zone where the mat vertically expands due to the resiliency of the glass fibers. This vertical expansion can be important in the manufacture process of commercially acceptable fiberglass thermal or acoustical insulation products. Subsequently, the coated mat is transferred to a curing oven where heated air is blown through the mat to cure the binder and rigidly attach the glass fibers together.
Phenol-formaldehyde (PF) resins, as well as phenol-formaldehyde resins extended with urea (PFU resins), are used in conventional processes, and have been relied on heavily over the past several years to prepare binders for fiberglass insulation products. Though these resins are inexpensive and provide the cured fiberglass insulation product with the desired physical properties, they may often have high free formaldehyde content, and a distinctive or unpleasant odor limiting their use in certain applications. Further, during the manufacture of fiberglass insulation, the potential for formaldehyde emissions and worker exposure is present. Therefore, manufacturing facilities using PF and PFU resins as the main binder component for insulation products are often required to install expensive abatement equipment in order to minimize the possible exposure of workers to formaldehyde emissions and to meet certain Maximum Achieveable Control Technology (MACT) requirement standards. Options for formaldehyde-free products or processes include i) adding a formaldehyde scavenger to the binder to reduce or remove free formaldehyde and thereby limit its subsequent emission and/or odor; ii) allowing the resin reaction to proceed for longer periods of time to reduce the free formaldehyde present in the resin product; or iii) utilizing formaldehyde-free resin formulations.
However, the use of scavengers may lead to precipitation, resulting from the scavenger itself and/or the adduct between the scavenger and any residual formaldehyde being insoluble, thereby necessitating additional and often expensive filtration steps. Further, allowing the resin reaction to proceed for an extended period of time sufficient to afford target formaldehyde levels results in a resin product having a concomitantly higher molecular weight. Such higher molecular weight resins may lack the desirable properties for some applications, as many tend to be sticky, causing the binder and the binder-coated fiberglass product to adhere to production equipment. Furthermore, higher molecular weight PF resins tend to have a higher “tetradimer” content. Tetradimer is a highly crystalline PF dimer present in phenolic resins produced under base-catalyzed conditions, which often precipitates readily. Precipitation is even more likely when free formaldehyde in the resin is scavenged. Tetradimer precipitation can result in plugged spray nozzles, and in precipitate formation in resin binder storage tanks and in the resin itself, necessitating removal.
Accordingly, as an alternative to PF and PFU resins, formaldehyde-free resin formulations have received increased attention for use as binders in making fiberglass insulation and other products. Suitable binder formulations advantageously have physical properties (e.g., viscosity, dilutability, and adhesiveness) and other characteristics similar to conventional PF and PFU resins, and can be made at low cost. Formulations that have a similar cure time and cure temperature profile, while yielding a cured fiberglass insulation product with equivalent physical properties, may allow the use of existing production equipment.
Aqueous binder compositions are described. In one aspect, the aqueous binder composition is formaldehyde-free. In another aspect, the aqueous binder composition is thermally-curable. In another aspect, the aqueous binder composition has an alkaline pH. In one illustrative embodiment, the aqueous binder composition cures to a formaldehyde-free, water-insoluble thermoset polyester resin. An aqueous binder composition for use in manufacturing fiber products, including non-woven fiber products such as fiber products composed of fiberglass and/or other fibers, including heat-resistant fibers and the like, is also described. The aqueous binder compositions and associated methods for using the binder compositions may include one or more of the features or combinations of features described herein.
In one illustrative embodiment, the aqueous binder composition includes a polyacid component having acid groups, or anhydride or salt derivatives thereof, and a polyhydroxy component having hydroxyl groups, where the pH of the binder composition is greater than about 7, and is illustratively in the range from about 7 to about 10. In another illustrative embodiment, the composition includes a polyacid component and a polyhydroxy component where the ratio of the number of molar equivalents of acid groups, or anhydride or salt derivatives thereof, present on the polyacid component to the number of molar equivalents of hydroxyl groups present on the polyhydroxy component is in the range from about 0.6:1 to about 1.2:1. In another illustrative embodiment, the composition includes a polyacid component that is a dicarboxylic acid, including, but not limited to, unsaturated aliphatic dicarboxylic acids, saturated aliphatic dicarboxylic acids, aromatic dicarboxylic acids, unsaturated cyclic dicarboxylic acids, saturated cyclic dicarboxylic acids, hydroxy-substituted derivatives thereof, and the like. In another illustrative embodiment, the composition includes a polyacid component that is a tricarboxylic acid, including, but not limited to, unsaturated aliphatic tricarboxylic acids, saturated aliphatic tricarboxylic acids, aromatic tricarboxylic acids, unsaturated cyclic tricarboxylic acids, saturated cyclic tricarboxylic acids, hydroxy-substituted derivatives thereof, and the like. In another illustrative embodiment, the composition includes a polyacid component that is a tetracarboxylic, pentacarboxylic, and like polycarboxylic acids, and salts and anhydride derivatives thereof, and combinations thereof. It is appreciated that any of these polyacids may be optionally substituted, such as with hydroxy, halo, alkyl, alkoxy, and the like. In one illustrative aspect, the composition is an alkaline composition, where the polyacid component is neutralized by the addition of a base or where certain salts of the polyacid component are used. In another illustrative embodiment, the composition includes a polyacid component, such as succinic acid, citric acid, or fumaric acid and the like that has been neutralized by the addition of a base, or is a salt. In another illustrative embodiment, the polyacid component is maleic acid neutralized with, for example, aqueous ammonia. In another illustrative embodiment, the polyacid component is the ammonium salt of maleate. In another illustrative embodiment, the polyhydroxy component is a partially hydrolyzed polyvinyl acetate, such as, for example, an ELVANOL (available from DuPont), or a polyvinyl alcohol. In another illustrative embodiment, the composition further includes a catalyst, such as an acid or an acid/salt, including inorganic and organic acids, and salts thereof. Illustrative organic acids include sulfonic acids and salts thereof, such as para-toluene sulfonic acid, ammonium para-toluene sulfonate, ammonium naphthalene disulfonate, and the like. It is appreciated that such catalysts may be capable of increasing the rate of ester formation during curing of the binder compositions described herein. In another illustrative embodiment, the composition further includes a silicon-containing compound, such as silylethers and alkylsilyl ethers. In one aspect, the silicon-containing compound is an amino-substituted silicon-containing compound, including, but not limited to, gamma-aminopropyltriethoxysilane. It is appreciated that the silicon-containing compound may serve as a coupling agent during curing of the binder compositions described herein.
In another illustrative embodiment, a method for treating fibers, including non-woven fibers, is described. In an illustrative aspect, the method includes contacting fibers with a thermally-curable, aqueous binder composition including a polyacid component and a polyhydroxy component, as described herein, wherein the pH of the binder composition is greater than 7, or, illustratively, is in the range from about 7 to about 10, and heating the thermally-curable, aqueous binder composition at an elevated temperature that is sufficient to cure the binder composition to form a polyester. In one aspect, the polyester is substantially water-insoluble. In another aspect, the polyester is a thermoset.
In another illustrative embodiment, a glass fiber product is described. The glass fiber product includes a composition obtained by heating a thermally-curable, aqueous binder composition that has been applied to fibers, such as a mat of non-woven fibers. In one aspect, the pH of the binder composition is greater than 7, or, illustratively, is in the range from about 7 to about 10. In one embodiment, the binder composition includes a polyacid component and a polyhydroxy component as described herein.
In an illustrative embodiment, a formaldehyde-free, thermally-curable, alkaline, aqueous binder composition is described. The binder composition includes a polyacid component having acid groups, or anhydride or salt derivatives thereof, and a polyhydroxy component having hydroxyl groups, where the pH of the binder composition is greater than 7, or, illustratively, is in the range from about 7 to about 10. The composition may be used as a binder for non-woven fibers, such as, for example, of fiberglass in the manufacture of insulation products. In one embodiment, it has been discovered that when a formaldehyde-free, alkaline, aqueous binder composition, including a polyacid component and a polyhydroxy component as described herein, is left for several days at room temperature or is heated for short periods of time in the absence of a catalyst capable of accelerating or increasing the rate of chemical reaction, a water-insoluble thermoset polyester resin is produced. Thus, a polyacid component has been found to be capable of reacting with a polyhydroxy component, under alkaline, aqueous conditions in the absence of a catalyst, to form a polyester resin.
In an illustrative embodiment, the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition is substantially unreacted when it is applied to a substrate, such as a sample of non-woven fibers. Upon heating, the binder is dried and thermal curing is accomplished. It is to be understood that the drying and thermal curing may occur either sequentially, contemporaneously, or concurrently. As used herein, the term “thermally-curable” is intended to indicate that a structural or morphological change in the aqueous binder occurs upon heating that is sufficient to alter the properties of non-woven fibers to which an effective amount of binder has been applied; such changes include, but are not necessarily limited to, covalent reaction of components of the binder, improved adhesion of the binder components to the substrate, and hydrogen bonding of binder components.
The term “formaldehyde-free,” as used herein, is meant to indicate that the aqueous binder composition is substantially free from formaldehyde, and does not liberate substantial formaldehyde as a result of drying and/or curing; typically, less than about 1 ppm formaldehyde, based on the weight of the composition, is present in a formaldehyde-free composition.
As used herein, the term “alkaline” is meant to indicate a solution pH that is greater than about 7, and is illustratively in the range from about 7 to about 10.
As used herein, the term “aqueous” includes water and mixtures composed substantially of water and other water-miscible solvents including, but not limited to, alcohols, ethers, amines, polar aprotic solvents, and the like.
As used herein, the terms “fiberglass,” “non-woven fiber,” and “glass fiber” are meant to indicate heat-resistant fibers suitable for withstanding elevated temperatures, such as mineral fibers, aramid fibers, ceramic fibers, metal fibers, carbon fibers, polyimide fibers, certain polyester fibers, rayon fibers, and glass fibers. Such fibers are substantially unaffected by exposure to temperatures above about 120° C.
In an illustrative embodiment, the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition includes a polyacid component having acid groups, or anhydride or salt derivative thereof. In one aspect, the polyacid component is sufficiently nonvolatile to maximize its ability to remain available for reaction with the polyhydroxy component. The polyacid component may be substituted with other chemical functional groups. It is appreciated that other functional groups are selected to minimize their interference with the preparation or formation of the polyester resin. Illustratively, the polyacid component may be a dicarboxylic acid, such as, for example, maleic acid. Other suitable polyacid components are contemplated to include, but are not limited to, aconitic acid, adipic acid, azelaic acid, butane tetracarboxylic acid dihydride, butane tricarboxylic acid, chlorendic acid, citraconic acid, citric acid, dicyclopentadiene-maleic acid adducts, diethylenetriamine pentaacetic acid, adducts of dipentene and maleic acid, endomethylenehexachlorophthalic acid, ethylenediamine tetraacetic acid (EDTA), fully maleated rosin, maleated tall oil fatty acids, fumaric acid, glutaric acid, isophthalic acid, itaconic acid, maleated rosin-oxidize unsaturation with potassium eroxide to alcohol then carboxylic acid, malic acid, mesaconic acid, biphenol A or isphenol F reacted via the KOLBE-Schmidt reaction with carbon dioxide to introduce 3-4 carboxyl groups, oxalic acid, phthalic acid, polylactic acid, sebacic acid, succinic acid, tartaric acid, terephthalic acid, tetrabromophthalic acid, tetrachlorophthalic acid, tetrahydrophthalic acid, trimellitic acid, and trimesic acid, and anhydrides and salts thereof, and combinations thereof.
In an illustrative embodiment, the acid groups of the polyacid component of the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition are neutralized with a base, and thereby converted to acid salt groups, prior to their reaction with the hydroxyl groups of the polyhydroxy component to form the polyester resin. It is understood that complete neutralization, i.e., about 100% calculated on an equivalents basis, may eliminate any need to titrate or partially neutralize acid groups in the polyacid component prior to polyester formation, but it is anticipated that less-than-complete neutralization would not inhibit formation of the polyester. “Base,” as used herein, refers to a base which may be substantially volatile or non-volatile under conditions sufficient to promote formation of the polyester. Illustratively, the base may be a volatile base, such as, for example, aqueous ammonia; alternatively, the base may be a non-volatile base, such as, for example, sodium carbonate, and other non-volatile bases, such as sodium hydroxide, potassium hydroxide, and the like are contemplated. Neutralization may be carried out either before or after the polyacid component is mixed with the polyhydroxy component.
In an illustrative embodiment, the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition also includes a polyhydroxy component having hydroxyl groups. In one aspect, the polyhydroxy component is sufficiently nonvolatile to maximize its ability to remain available for reaction with the polyacid component. The polyhydroxy component may be a polyvinyl alcohol, a partially hydrolyzed polyvinyl acetate, or mixtures thereof. Illustratively, when a partially hydrolyzed polyvinyl acetate serves as the polyhydroxy component, an 87-89% hydrolyzed polyvinyl acetate may be utilized, such as, for example, DuPont ELVANOL 51-05, which has a molecular weight of about 22,000-26,000 Da and a viscosity of 5.0-6.0 centipoises. Other partially hydrolyzed polyvinyl acetates contemplated to be useful include, but are not limited to, 87-89% hydrolyzed polyvinyl acetates differing in molecular weight and viscosity from ELVANOL 51-05, such as, for example, DuPont ELVANOL 51-04, ELVANOL 51-08, ELVANOL 50-14, ELVANOL 52-22, ELVANOL 50-26, and ELVANOL 50-42; and partially hydrolyzed polyvinyl acetates differing in molecular weight, viscosity, and degree of hydrolysis from ELVANOL 51-05, such as, for example, DuPont ELVANOL 51-03 (86-89% hydrolyzed), ELVANOL 70-14 (95.0-97.0% hydrolyzed), ELVANOL 70-27 (95.5-96.5% hydrolyzed), ELVANOL 60-30 (90-93% hydrolyzed), ELVANOL 70-03 (98.0-98.8% hydrolyzed), ELVANOL 70-04 (98.0-98.8% hydrolyzed), ELVANOL 70-06 (98.5-99.2% hydrolyzed), ELVANOL 90-50 (99.0-99.8% hydrolyzed), ELVANOL 70-20 (98.5-99.2% hydrolyzed), ELVANOL 70-30 (98.5-99.2% hydrolyzed), ELVANOL 71-30 (99.0-99.8% hydrolyzed), ELVANOL 70-62 (98.4-99.8% hydrolyzed), ELVANOL 70-63 (98.5-99.2% hydrolyzed), and ELVANOL 70-75 (98.5-99.2% hydrolyzed).
In an illustrative embodiment, the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition may also include a catalyst capable of increasing the rate of polyester formation during curing of the binder compositions described herein. Illustratively, the catalyst may be an ammonium salt, such as, for example, ammonium para-toluene sulfonate or ammonium naphthalene disulfonate. Other suitable catalysts are contemplated to include, but are not limited to, ammonium sulfate, ammonium chloride, sulfuric acid, lactic acid, lead acetate, sodium acetate, calcium acetate, zinc acetate, organotin compounds, titanium esters, antimony trioxide, germanium salts, sodium hypophosphite, sodium phosphite, methane sulfonic acid and para-toluene sulfonic acid, and mixtures thereof. Although additional catalysts may be contemplated, it is to be understood that the binder compositions described herein neither require nor are limited to any particular catalyst composition or amount thereof and the addition of such compounds is optional.
In an illustrative embodiment, the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition may also include a silicon-containing coupling agent (e.g., organo-silicon oil). Silicon-containing coupling agents have been marketed by the Dow-Corning Corporation, Petrarch Systems, and by the General Electric Company. Their formulation and manufacture are well known such that detailed description thereof need not be provided. Illustratively, the silicon-containing coupling agent may be compounds such as silylethers and alkylsilyl ethers. In one aspect, the silicon-containing compound is an amino-substituted silane, such as, for example, gamma-aminopropyltriethoxy silane (Dow SILQUEST A-1101). When employed in an illustrative embodiment, silicon-containing coupling agents typically are present in the binder composition in an amount within the range of about 0.1 to about 2.0 percent by weight based upon the binder solids. It is to be understood that the binder compositions described herein neither require nor are limited to any particular silicon-containing compound or amount thereof and the addition of such compounds is optional.
In an illustrative embodiment, the formaldehyde-free, thermally-curable, alkaline, aqueous binder composition may be prepared by admixing a 10-50 weight percent aqueous solution of a polyacid component, already neutralized or neutralized in the presence of the polyhydroxy component, a 10-30 weight percent aqueous solution of a polyhydroxy component, and, if desired, an aqueous solution of a catalyst capable of increasing the rate of polyester formation during curing, and also, if desired, a silicon-containing coupling agent. By varying the polyacid component, the polyhydroxy component, and optional catalyst and silicon-containing coupling agent compositions, the initial concentrations thereof, and the mixing ratio of solutions, a wide range of binder solution compositions can be prepared, wherein the pH of the binder composition is alkaline, and illustratively in the range from about 7 to about 10. Thus, while avoiding acidic binder compositions, which tend to cause corrosion problems in manufacturing equipment, the health-related and compliance-related benefits provided by a formaldehyde-free composition are maintained. Further, the alkaline, formaldehyde-free binder compositions described herein provide advantages of permitting the use of existing manufacturing equipment in fiberglass manufacturing plants and eliminating the need to retrofit such plants with stainless steel equipment.
The following examples illustrate embodiments of the invention in further detail. These examples are provided for illustrative purposes only and should not be construed as limiting the invention or the inventive concept to any particular physical configuration. For example, although the ratio of the number of molar equivalents of acid groups, or anhydride or salt derivatives thereof, in the polyacid component to the number of molar equivalents of hydroxyl groups in the polyhydroxy component is in the range of from about 0.6:1 to about 1.2:1, it is to be understood that, in variation of the embodiments described herein, these ratios may be altered without affecting the nature of the invention described.
ELVANOL 51-05 was prepared as a 14.5% solution in water (17.25 g of ELVANOL 51-05 per 119 g of solution).
To 205 g of water being stirred at room temperature were added successively 118.5 g of a 14.5% solution of ELVANOL 51-05 (17.2 g) and 76 g of a 30% solution of maleic acid (22.8 g) to produce approximately 400 g of clear, colorless solution. To 50 g of ELVANOL 51-05/maleic acid solution were added 20.3 g of an 18% solution of sodium carbonate (3.65 g). The resulting mixture was stirred at room temperature to produce approximately 70.3 g of hazy solution. This solution exhibited a pH of 8, and consisted of approximately 24.8% ELVANOL 51-05, 32.9% maleic acid, and 42.2% sodium carbonate (as a relative percentage of total dissolved solids), and contained about 12% dissolved solids (as a percentage of total weight of solution).
To 50 g of ELVANOL 51-05/maleic acid solution, prepared as described in Example 2, were added 0.3 g of an 18% solution of sodium carbonate (0.05 g). The resulting mixture was stirred at room temperature to produce approximately 50.3 g of solution. This solution consisted of approximately 42.6% ELVANOL 51-05, 56.4% maleic acid, and 1.0% sodium carbonate (as a relative percentage of total dissolved solids), and contained about 10% dissolved solids (as a percentage of total weight of solution).
To 50 g of ELVANOL 51-05/maleic acid solution, prepared as described in Example 2, were added 6 g of a 19% solution of ammonia. The resulting mixture was stirred at room temperature to produce approximately 56 g of solution. This solution exhibited a pH of 9.5, and consisted of approximately 43.0% ELVANOL 51-05 and 57.0% maleic acid (as a relative percentage of total dissolved solids), and contained about 9% dissolved solids (as a percentage of total weight of solution).
To 127 g of water being stirred at room temperature were added successively 80 g of a 14.5% solution of ELVANOL 51-05 (11.6 g) and 73 g of a 27% solution of ammonium maleate (equivalent to 15.3 g of maleic acid solids) to produce approximately 280 g of clear, colorless solution. This solution exhibited a pH of 7.94 (after 9 days), and consisted of approximately 43% ELVANOL 51-05 and 57% maleic acid (as a relative percentage of total dissolved solids), and contained about 10% dissolved solids (as a percentage of total weight of solution). Upon standing for eleven days at room temperature, a tough, insoluble film was observed on the bottom of the reaction flask.
To 50 g of ELVANOL 51-05/ammonium maleate solution, prepared as described in Example 5, were added 20 g of a 15% solution of ammonium para-toluene sulfonate (3 g). The resulting mixture was stirred for approximately 5 minutes at room temperature to produce approximately 70 g of clear, colorless solution. This solution exhibited a pH of 8.28, and consisted of approximately 26.5% ELVANOL 51-05, 35.0% maleic acid, and 38.5% ammonium para-toluene sulfonate (as a relative percentage of total dissolved solids), and contained about 11% dissolved solids (as a percentage of total weight of solution).
To 50 g of ELVANOL 51-05/ammonium maleate solution, prepared as described in Example 5, were added 3.3 g of a 15% solution of ammonium para-toluene sulfonate (0.5 g). The resulting mixture was stirred for approximately 9 minutes at room temperature to produce approximately 53.3 g of clear, colorless solution. This solution exhibited a pH of 8.17, and consisted of approximately 39.1% ELVANOL 51-05, 51.5% maleic acid, and 9.4% ammonium para-toluene sulfonate (as a relative percentage of total dissolved solids), and contained about 10% dissolved solids (as a percentage of total weight of solution).
To 148 g of water being stirred at room temperature were added successively 303 g of a 14.5% solution of ELVANOL 51-05 (43.9 g), 147 g of a 27% solution of ammonium maleate (equivalent to 30.9 g of maleic acid solids), 67 g of a 15% solution of ammonium para-toluene sulfonate (10.0 g), and 2.0 g of SILQUEST A-1101 silane to produce approximately 667 g of solution. This solution exhibited a pH of 8.61, and consisted of approximately 50.6% ELVANOL 51-05, 35.6% maleic acid, 11.5% ammonium para-toluene sulfonate, and 2.3% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 13% dissolved solids (as a percentage of total weight of solution).
To 162 g of water being stirred at room temperature were added successively 276 g of a 14.5% solution of ELVANOL 51-05 (40.0 g), 160 g of a 27% solution of ammonium maleate (equivalent to 33.6 g of maleic acid solids), 67 g of a 15% solution of ammonium para-toluene sulfonate (10.0 g), and 2.0 g of SILQUEST A-1101 silane to produce approximately 667 g of solution. This solution exhibited a pH of 8.60, and consisted of approximately 46.7% ELVANOL 51-05, 39.3% maleic acid, 11.7% ammonium para-toluene sulfonate, and 2.3% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 13% dissolved solids (as a percentage of total weight of solution).
To 54 g of water being stirred at room temperature were added successively 72 g of a 14.5% solution of ELVANOL 51-05 (10.4 g), 53 g of a 27% solution of ammonium maleate (equivalent to 11.1 g of maleic acid solids), 20 g of a 15% solution of ammonium para-toluene sulfonate (3 g), and 0.6 g of SILQUEST A-1101 silane to produce approximately 200 g of solution. This solution exhibited a pH of 8.58, and consisted of approximately 41.4% ELVANOL 51-05, 44.2% maleic acid, 11.9% ammonium para-toluene sulfonate, and 2.4% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 12% dissolved solids (as a percentage of total weight of solution).
To 58 g of water being stirred at room temperature were added successively 64 g of a 14.5% solution of ELVANOL 51-05 (9.3 g), 57 g of a 27% solution of ammonium maleate (equivalent to 12.0 g of maleic acid solids), 20 g of a 15% solution of ammonium para-toluene sulfonate (3 g), and 0.6 g of SILQUEST A-1101 silane to produce approximately 200 g of solution. This solution exhibited a pH of 8.59, and consisted of approximately 37.3% ELVANOL 51-05, 48.2% maleic acid, 12.0% ammonium para-toluene sulfonate, and 2.4% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 12% dissolved solids (as a percentage of total weight of solution).
To 126 g of water being stirred at room temperature were added successively 80 g of a 14.5% solution of ELVANOL 51-05 (11.6 g), 20 g of a 15% solution of ammonium para-toluene sulfonate (3 g), 73 g of a 27% solution of ammonium maleate (equivalent to 15.3 g of maleic acid solids), and 0.65 g of SILQUEST A-1101 silane to produce approximately 300 g of clear, colorless solution. This solution exhibited a pH of 8.15 (at +17 hours), and consisted of approximately 38.0% ELVANOL 51-05, 50.1% maleic acid, 9.8% ammonium para-toluene sulfonate, and 2.1% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 10% dissolved solids (as a percentage of total weight of solution).
To 126 g of water being stirred at room temperature were added successively 80 g of a 14.5% solution of ELVANOL 51-05 (11.6 g), 73 g of a 27% solution of ammonium maleate (equivalent to 15.3 g of maleic acid solids), 120 g of a 15% solution of ammonium para-toluene sulfonate (18 g), and 0.63 g of SILQUEST A-1101 silane to produce approximately 400 g of clear, colorless solution. This solution exhibited a pH of 7.91 (at +17 hours), and consisted of approximately 25.5% ELVANOL 51-05, 33.6% maleic acid, 39.5% ammonium para-toluene sulfonate, and 1.4% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 11% dissolved solids (as a percentage of total weight of solution).
To 126 g of water being stirred at room temperature were added successively 80 g of a 14.5% solution of ELVANOL 51-05 (11.6 g), 73 g of a 27% solution of ammonium maleate (equivalent to 15.3 g of maleic acid solids), 10 g of a 30% solution of ammonium naphthalene disulfonate (3 g), and 0.6 g of SILQUEST A-1101 silane to produce approximately 290 g of clear, colorless solution. This solution exhibited a pH of 7.89 (at +17 hours), and consisted of approximately 38.0% ELVANOL 51-05, 50.2% maleic acid, 9.8% ammonium naphthalene disulfonate, and 2.0% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 10% dissolved solids (as a percentage of total weight of solution).
To 81 g of a 51% solution of T 2894 phenol-formaldehyde resin (41.3 g) were added 35 g of a 40% solution of urea (14 g). The resulting solution was stirred at room temperature and then were added successively 251 g of water, 7.9 g of a 19% solution of ammonia, 23.3 g of a 15% solution of ammonium para-toluene sulfonate (3.5 g), and 1.05 g of SILQUEST A-1101 silane to produce approximately 400 g of clear, colorless solution. This solution exhibited a pH of 8.14, and consisted of approximately 69.0% T 2894 phenol-formaldehyde resin, 23.4% urea, 5.8% ammonium para-toluene sulfonate, and 1.8% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 15% dissolved solids (as a percentage of total weight of solution).
To 112.98 g of a 25.3% solution of Rohm-Haas T SET #1 (28.6 g) were added 77.58 g of water to produce approximately 190.56 g of clear, colorless solution. This solution, consisting of 100% T SET #1 (as a relative percentage of total dissolved solids), exhibited a pH of 4.08 and contained about 15% dissolved solids (as a percentage of total weight of solution).
To 99.75 g of Rohm-Haas T SET #1 solution, prepared as described in Example 16, were added 0.23 g of SILQUEST A-1101 silane to produce approximately 100 g of clear, colorless solution. This solution exhibited a pH of 4.06, and consisted of approximately 98.5% T SET #1 and 1.5% SILQUEST A-1101 silane (as a relative percentage of total dissolved solids), and contained about 15% dissolved solids (as a percentage of total weight of solution).
In order to evaluate aqueous binder compositions under thermal curing conditions, 1-g samples of each binder composition were placed onto one or more individual aluminum plates. Each binder composition was then subjected to one or more of the following bake-out/cure conditions in pre-heated ovens in order to produce the corresponding cured binder sample: 0.5 hour at 300° F. and 0.5 hour at 350° F.
Dry flexibility, dry strength, and wet strength were determined for cured binder samples on a scale ranging from 0, corresponding to none, to 10, corresponding to excellent, as follows: Dry flexibility was determined as the extent to which a binder sample, generally present as a film adhering to the aluminum plate, resisted breaking upon flexing the plate metal. Dry strength was determined as the extent to which a binder sample remained intact and resisted breakage following removal from a pre-heated oven. Wet strength was determined as the extent to which a binder sample appeared to have cured, as indicated by its tendency either to adhere to the surface of the aluminum plate as an intact, solid mass or, if not adherent, to remain intact and resist breakage, following addition of 10 mL of water and subsequent standing overnight at room temperature. Complete dissolution of a binder sample in 10 mL of water corresponded to a wet strength value of 0. The appearance of cured binder samples was also determined. Results are presented in Table 1.
While certain embodiments of the present invention have been described and/or exemplified above, it is contemplated that considerable variation and modification thereof are possible. Accordingly, the present invention is not limited to the particular embodiments described and/or exemplified herein.
This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 60/552,361, filed Mar. 11, 2004, the disclosure of which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1801052 | Meigs | Apr 1931 | A |
| 1801053 | Meigs | Apr 1931 | A |
| 1886353 | Novotny et al. | Nov 1932 | A |
| 2392105 | Sussman | Jan 1946 | A |
| 3232821 | Moore et al. | Feb 1966 | A |
| 3802897 | Voigt et al. | Apr 1974 | A |
| 3809664 | Fanta et al. | May 1974 | A |
| 3826767 | Hoover et al. | Jul 1974 | A |
| 3856606 | Fan et al. | Dec 1974 | A |
| 3911048 | Vargiu et al. | Oct 1975 | A |
| 4028290 | Reid | Jun 1977 | A |
| 4048127 | Gibbons et al. | Sep 1977 | A |
| 4054713 | Sakaguchi et al. | Oct 1977 | A |
| 4097427 | Aitken et al. | Jun 1978 | A |
| 4107379 | Stofko | Aug 1978 | A |
| 4148765 | Nelson | Apr 1979 | A |
| 4183997 | Stofko | Jan 1980 | A |
| 4233432 | Curtis, Jr. | Nov 1980 | A |
| 4246367 | Curtis, Jr. | Jan 1981 | A |
| 4278573 | Tessler | Jul 1981 | A |
| 4296173 | Fahey | Oct 1981 | A |
| 4301310 | Wagner | Nov 1981 | A |
| 4330443 | Rankin | May 1982 | A |
| 4357194 | Stofko | Nov 1982 | A |
| 4400496 | Butler et al. | Aug 1983 | A |
| 4464523 | Neigel et al. | Aug 1984 | A |
| 4524164 | Viswanathan et al. | Jun 1985 | A |
| 4668716 | Pepe et al. | May 1987 | A |
| 4692478 | Viswanathan et al. | Sep 1987 | A |
| 4754056 | Ansel et al. | Jun 1988 | A |
| 4845162 | Schmitt et al. | Jul 1989 | A |
| 4906237 | Johansson et al. | Mar 1990 | A |
| 4912147 | Pfoehler et al. | Mar 1990 | A |
| 4923980 | Blomberg | May 1990 | A |
| 5037930 | Shih | Aug 1991 | A |
| 5041595 | Yang et al. | Aug 1991 | A |
| 5095054 | Lay et al. | Mar 1992 | A |
| 5106615 | Dikstein | Apr 1992 | A |
| 5114004 | Isono et al. | May 1992 | A |
| 5124369 | Vandichel et al. | Jun 1992 | A |
| 5151465 | Le-Khac | Sep 1992 | A |
| 5308896 | Hansen et al. | May 1994 | A |
| 5318990 | Strauss | Jun 1994 | A |
| 5336753 | Jung et al. | Aug 1994 | A |
| 5336755 | Pape | Aug 1994 | A |
| 5340868 | Strauss et al. | Aug 1994 | A |
| 5371194 | Ferretti | Dec 1994 | A |
| 5387665 | Misawa et al. | Feb 1995 | A |
| 5393849 | Srinivasan et al. | Feb 1995 | A |
| 5434233 | Kiely et al. | Jul 1995 | A |
| 5480973 | Goodlad et al. | Jan 1996 | A |
| 5498662 | Tanaka et al. | Mar 1996 | A |
| 5536766 | Seyffer et al. | Jul 1996 | A |
| 5547541 | Hansen et al. | Aug 1996 | A |
| 5571618 | Hansen et al. | Nov 1996 | A |
| 5578678 | Hartmann et al. | Nov 1996 | A |
| 5582682 | Ferretti | Dec 1996 | A |
| 5583193 | Aravindakshan et al. | Dec 1996 | A |
| 5609727 | Hansen et al. | Mar 1997 | A |
| 5614570 | Hansen et al. | Mar 1997 | A |
| 5620940 | Birbara et al. | Apr 1997 | A |
| 5621026 | Tanaka et al. | Apr 1997 | A |
| 5633298 | Arfaei et al. | May 1997 | A |
| 5643978 | Darwin et al. | Jul 1997 | A |
| 5645756 | Dubin et al. | Jul 1997 | A |
| 5661213 | Arkens et al. | Aug 1997 | A |
| 5691060 | Levy | Nov 1997 | A |
| 5693411 | Hansen et al. | Dec 1997 | A |
| 5756580 | Natori et al. | May 1998 | A |
| 5855987 | Margel et al. | Jan 1999 | A |
| 5885337 | Nohr et al. | Mar 1999 | A |
| 5895804 | Lee et al. | Apr 1999 | A |
| 5919831 | Philipp | Jul 1999 | A |
| 5925722 | Exner et al. | Jul 1999 | A |
| 5929184 | Holmes-Farley et al. | Jul 1999 | A |
| 5932344 | Ikemoto et al. | Aug 1999 | A |
| 5932665 | DePorter et al. | Aug 1999 | A |
| 5932689 | Arkens et al. | Aug 1999 | A |
| 5942123 | McArdle | Aug 1999 | A |
| 5977224 | Cheung et al. | Nov 1999 | A |
| 5977232 | Arkens et al. | Nov 1999 | A |
| 5981719 | Woiszwillo et al. | Nov 1999 | A |
| 5983586 | Berdan, II et al. | Nov 1999 | A |
| 5990216 | Cai et al. | Nov 1999 | A |
| 6072086 | James et al. | Jun 2000 | A |
| 6077883 | Taylor et al. | Jun 2000 | A |
| 6090925 | Woiszwillo et al. | Jul 2000 | A |
| 6114033 | Ikemoto et al. | Sep 2000 | A |
| 6114464 | Reck et al. | Sep 2000 | A |
| 6136916 | Arkens et al. | Oct 2000 | A |
| 6171654 | Salsman et al. | Jan 2001 | B1 |
| 6210472 | Kwan et al. | Apr 2001 | B1 |
| 6221973 | Arkens et al. | Apr 2001 | B1 |
| 6310227 | Sarama et al. | Oct 2001 | B1 |
| 6313102 | Colaco et al. | Nov 2001 | B1 |
| 6319683 | James et al. | Nov 2001 | B1 |
| 6331350 | Taylor et al. | Dec 2001 | B1 |
| 6379739 | Formanek et al. | Apr 2002 | B1 |
| 6395856 | Petty et al. | May 2002 | B1 |
| 6440204 | Rogols et al. | Aug 2002 | B1 |
| 6468442 | Bytnar | Oct 2002 | B2 |
| 6468730 | Fujiwara et al. | Oct 2002 | B2 |
| 6482875 | Lorenz et al. | Nov 2002 | B2 |
| 6495656 | Haile et al. | Dec 2002 | B1 |
| 6525009 | Sachdev et al. | Feb 2003 | B2 |
| 6613378 | Erhan et al. | Sep 2003 | B1 |
| 6638884 | Quick et al. | Oct 2003 | B2 |
| 6753361 | Kroner et al. | Jun 2004 | B2 |
| 6852247 | Bytnar | Feb 2005 | B2 |
| 6858074 | Anderson et al. | Feb 2005 | B2 |
| 6861495 | Barsotti et al. | Mar 2005 | B2 |
| 6864044 | Ishikawa et al. | Mar 2005 | B2 |
| 6955844 | Tagge et al. | Oct 2005 | B2 |
| 7029717 | Ojima et al. | Apr 2006 | B1 |
| 7067579 | Taylor et al. | Jun 2006 | B2 |
| 7090745 | Beckman et al. | Aug 2006 | B2 |
| 7141626 | Rodrigues et al. | Nov 2006 | B2 |
| 7195792 | Boston et al. | Mar 2007 | B2 |
| 7201778 | Smith et al. | Apr 2007 | B2 |
| 20020032253 | Lorenz et al. | Mar 2002 | A1 |
| 20020091185 | Taylor et al. | Jul 2002 | A1 |
| 20020161108 | Schultz et al. | Oct 2002 | A1 |
| 20030005857 | Minami et al. | Jan 2003 | A1 |
| 20040019168 | Soerens et al. | Jan 2004 | A1 |
| 20040033747 | Miller et al. | Feb 2004 | A1 |
| 20040038017 | Tutin et al. | Feb 2004 | A1 |
| 20040077055 | Fosdick et al. | Apr 2004 | A1 |
| 20040122166 | O'Brien-Bernini et al. | Jun 2004 | A1 |
| 20040152824 | Dobrowolski | Aug 2004 | A1 |
| 20040249066 | Heinzman et al. | Dec 2004 | A1 |
| 20040254285 | Rodrigues et al. | Dec 2004 | A1 |
| 20050059770 | Srinivasan et al. | Mar 2005 | A1 |
| 20050171085 | Pinto et al. | Aug 2005 | A1 |
| 20050196421 | Hunter et al. | Sep 2005 | A1 |
| 20050215153 | Cossement et al. | Sep 2005 | A1 |
| 20050275133 | Cabell et al. | Dec 2005 | A1 |
| 20060099870 | Garcia et al. | May 2006 | A1 |
| 20060135433 | Murray et al. | Jun 2006 | A1 |
| 20060252855 | Pisanova et al. | Nov 2006 | A1 |
| 20070006390 | Clamen et al. | Jan 2007 | A1 |
| 20070009582 | Madsen et al. | Jan 2007 | A1 |
| Number | Date | Country |
|---|---|---|
| 0 524 518 | Jul 1992 | EP |
| 0 547 819 | Dec 1992 | EP |
| 0 583 086 | Feb 1994 | EP |
| 0 672 720 | Mar 1995 | EP |
| 0 714 754 | Jun 1996 | EP |
| 0 826 710 | Mar 1998 | EP |
| 0 873 976 | Oct 1998 | EP |
| 0 882 756 | Dec 1998 | EP |
| 0 911 361 | Apr 1999 | EP |
| 0 990 729 | Apr 2000 | EP |
| 1 038 433 | Sep 2000 | EP |
| 1 193 288 | Sep 2001 | EP |
| 1 225 193 | Jul 2002 | EP |
| 1 486 547 | Jun 2004 | EP |
| 2 614 388 | Oct 1988 | FR |
| 2 078 805 | Jan 1982 | GB |
| 58011193 | Jan 1983 | JP |
| 03173680 | Jul 1991 | JP |
| 07034023 | Mar 1995 | JP |
| 2004-60058 | Feb 2004 | JP |
| 374400 | Mar 1973 | SU |
| 9947765 | Sep 1999 | WO |
| 03071879 | Sep 2003 | WO |
| WO 2004076734 | Sep 2004 | WO |
| 2006044302 | Apr 2006 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20050202224 A1 | Sep 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60552361 | Mar 2004 | US |
